Current and future considerations for the use of immune checkpoint inhibitors in NSCLC

from touchPODCAST · host touchpodcast

Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives. The expert Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchRESPIRATORY

Episode metadata supplied by the publisher feed · Published Jul 10, 2023

Embed this episode

Attribution link and audio player

Ready to play

Current and future considerations for the use of immune checkpoint inhibitors in NSCLC

0:00 33:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 33 minutes long.

When was this touchPODCAST episode published?

This episode was published on July 10, 2023.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!